Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company, developing immunotherapies designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs.